
ONCOLYTICS BIOTECH INC
ONCOLYTICS BIOTECH INC (ONCY)
WebsitePrice
Market cap
Next catalystDec 12, 2026pelareorep + bortezomib + dexamethasone + pembrolizumab — multiple myeloma · Phase 1/2 dataCompany source ↗
Cash
Chart & Events
Core Clinical
PreINDP1P2P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
PreINDP1P2P3FilingApproved
Other pipelines
PreINDP1P2P3FilingApproved